4th Pricing & Reimbursement Conference 2017

Topics

• Global economic crisis, austerity , health budgets & reforms
• HTA agency policy and practice globally
• Lessons learnt from interational experience of VBP
• Innovation in medical devices
• Orphan drug P&R in Europe are the payors biting back ?
• Updates on market-access & risk sharing schemes

Who should Attend

Scientists involved in Pricing & Reimbursement from academia, biotech, pharmaceutical or medical device industry.